Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.13 USD | +0.30% | +0.40% | +0.70% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.70% | 1.37B | |
+9.30% | 46.03B | |
+52.73% | 44.55B | |
+7.15% | 40.8B | |
-8.78% | 28.25B | |
+18.68% | 27.71B | |
-21.92% | 18.82B | |
+14.62% | 13.91B | |
+31.85% | 12.43B | |
+4.47% | 10.81B |
- Stock
- Equities
- Stock Vir Biotechnology, Inc. - Nasdaq
- News Vir Biotechnology, Inc.
- Vir Biotechnology Doses First Patients in Phase 2 SOLSTICE Trial Evaluating Chronic Hepatitis D Virus Infection